| Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ... Atherosclerosis 277, 234-255, 2018 | 186 | 2018 |
| Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia Z Ademi, GF Watts, J Pang, EJG Sijbrands, FM Van Bockxmeer, P O'Leary, ... Journal of clinical lipidology 8 (4), 390-400, 2014 | 185 | 2014 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 176 | 2021 |
| Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action KA Wilemon, J Patel, C Aguilar-Salinas, CD Ahmed, M Alkhnifsawi, ... JAMA cardiology 5 (2), 217-229, 2020 | 173 | 2020 |
| Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care GF Watts, SS Gidding, P Mata, J Pang, DR Sullivan, S Yamashita, FJ Raal, ... Nature Reviews Cardiology 17 (6), 360-377, 2020 | 116 | 2020 |
| Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies DC Chan, J Pang, G Romic, GF Watts Current atherosclerosis reports 15, 1-9, 2013 | 101 | 2013 |
| Prevalence and treatment of familial hypercholesterolaemia in Australian communities GF Watts, JE Shaw, J Pang, DJ Magliano, GLR Jennings, MJ Carrington International journal of cardiology 185, 69-71, 2015 | 99 | 2015 |
| Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit J Pang, EB Poulter, DA Bell, TR Bates, VL Jefferson, GS Hillis, CJ Schultz, ... Journal of clinical lipidology 9 (5), 703-708, 2015 | 96 | 2015 |
| Elevated lipoprotein (a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial … DC Chan, J Pang, AJ Hooper, JR Burnett, DA Bell, TR Bates, ... International journal of cardiology 201, 633-638, 2015 | 90 | 2015 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 87 | 2022 |
| Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience DA Bell, J Pang, S Burrows, TR Bates, FM van Bockxmeer, AJ Hooper, ... Atherosclerosis 239 (1), 93-100, 2015 | 81 | 2015 |
| Simplified Canadian definition for familial hypercholesterolemia I Ruel, D Brisson, S Aljenedil, Z Awan, A Baass, A Bélanger, J Bergeron, ... Canadian Journal of Cardiology 34 (9), 1210-1214, 2018 | 78 | 2018 |
| Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia GF Watts, DR Sullivan, DL Hare, KM Kostner, AE Horton, DA Bell, T Brett, ... Heart, Lung and Circulation 30 (3), 324-349, 2021 | 73 | 2021 |
| Plasma proprotein convertase subtilisin kexin type 9 as a predictor of carotid atherosclerosis in asymptomatic adults DC Chan, J Pang, BM McQuillan, J Hung, JP Beilby, PHR Barrett, ... Heart, Lung and Circulation 25 (5), 520-525, 2016 | 70 | 2016 |
| Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services AW Vickery, D Bell, J Garton-Smith, AB Kirke, J Pang, GF Watts Heart, Lung and Circulation 23 (12), 1158-1164, 2014 | 68 | 2014 |
| Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia DA Bell, J Garton-Smith, A Vickery, AB Kirke, J Pang, TR Bates, GF Watts Heart, Lung and Circulation 23 (4), 309-313, 2014 | 66 | 2014 |
| Prevalence of familial hypercholesterolemia in adolescents: potential value of universal screening? J Pang, AC Martin, TA Mori, LJ Beilin, GF Watts The Journal of pediatrics 170, 315-316, 2016 | 64 | 2016 |
| Predicting self-management behaviors in familial hypercholesterolemia using an integrated theoretical model: the impact of beliefs about illnesses and beliefs about behaviors MS Hagger, SJ Hardcastle, C Hingley, E Strickland, J Pang, GF Watts International Journal of Behavioral Medicine 23, 282-294, 2016 | 62 | 2016 |
| Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp (a) and ApoB-100–Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes Mellitus EM Ooi, GF Watts, DC Chan, J Pang, VS Tenneti, SJ Hamilton, ... Arteriosclerosis, thrombosis, and vascular biology 35 (12), 2686-2693, 2015 | 62 | 2015 |
| A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice L Troeung, D Arnold-Reed, WCS Ping-Delfos, GF Watts, J Pang, ... Heart 102 (11), 855-861, 2016 | 61 | 2016 |
